A M Drewes Selected Research

A M Drewes Research Topics

Disease

23	Pain (Aches) 06/2022 - 01/2000
6	Chronic Pain 06/2022 - 10/2011
6	Hyperalgesia 10/2011 - 01/2000
4	Hypersensitivity (Allergy) 01/2018 - 10/2004
4	Gastroesophageal Reflux (GERD) 01/2018 - 10/2005
4	Visceral Pain 06/2015 - 10/2004
3	Adenocarcinoma 10/2014 - 05/2014
3	Neurogenic Inflammation 10/2009 - 02/2003
2	Chronic Pancreatitis 01/2020 - 10/2011
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2018 - 01/2017
2	Constipation 01/2016 - 03/2013
2	Myalgia 10/2011 - 01/2000
2	Referred Pain 10/2004 - 01/2000
1	Pancreatitis 06/2022
1	Ankylosing Spondylitis 01/2021
1	Psoriatic Arthritis 01/2021
1	Rheumatoid Arthritis 01/2021
1	Inflammation (Inflammations) 01/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Necrosis 01/2018
1	Motor Disorders 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 12/2017
1	Hypercapnia 12/2017
1	Barrett Esophagus (Barrett's Esophagus) 04/2017
1	Postoperative Pain 01/2017
1	Fructose Intolerance (Intolerance, Fructose) 01/2017
1	Flatulence 01/2017
1	Diabetes Mellitus 01/2017
1	Lactose Intolerance (Intolerance, Lactose) 01/2017
1	Pruritus (Itching) 01/2017
1	Musculoskeletal Pain 04/2016
1	Diabetic Neuropathies (Diabetic Neuropathy) 07/2014
1	Neoplasms (Cancer) 05/2014
1	Burns 10/2011
1	Systemic Scleroderma (Systemic Sclerosis) 09/2009
1	Esophageal Achalasia (Megaesophagus) 10/2005
1	Acute Cholecystitis 10/2004
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 08/2001

Drug/Important Bio-Agent (IBA)

9	Opioid Analgesics (Opioids)IBA 06/2022 - 10/2011
5	AcidsIBA 04/2017 - 12/2009
5	Analgesics (Analgesic Drugs)IBA 11/2015 - 10/2011
4	Pharmaceutical PreparationsIBA 12/2017 - 05/2011
4	Oxycodone (Oxycontin)FDA LinkGeneric 12/2017 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 04/2017 - 08/2001
3	Morphine (MS Contin)FDA LinkGeneric 11/2015 - 02/2014
3	Proton Pump InhibitorsIBA 10/2014 - 05/2014
3	Capsaicin (Zostrix)FDA Link 10/2011 - 02/2003
2	Indicators and Reagents (Reagents)IBA 06/2022 - 01/2000
2	CytokinesIBA 01/2021 - 01/2018
2	Tapentadol FDA Link 12/2017 - 07/2014
2	Lactose FDA LinkGeneric 01/2017 - 01/2017
2	HydrogenIBA 01/2017 - 01/2017
2	FructoseIBA 01/2017 - 01/2017
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2016 - 07/2014
2	Serotonin (5 Hydroxytryptamine)IBA 12/2016 - 01/2000
2	Opioid Receptors (Opioid Receptor)IBA 07/2014 - 10/2011
2	Dihydrotachysterol (AT 10)IBA 03/2013 - 01/2000
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 06/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Interleukin-1 (Interleukin 1)IBA 01/2018
1	Capsules (Microcapsules)IBA 01/2017
1	SugarsIBA 01/2017
1	Pirinitramide (Piritramide)IBA 01/2017
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 12/2016
1	Antidepressive Agents (Antidepressants)IBA 12/2016
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 12/2016
1	AntralIBA 04/2016
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 04/2016
1	salicylhydroxamic acid (SHAM)IBA 04/2016
1	methylnaltrexone FDA Link 05/2015
1	NAD (NADH)IBA 07/2014
1	antineoplaston A10 (A 10)IBA 05/2014
1	Fentanyl (Sublimaze)FDA LinkGeneric 10/2011
1	Buprenorphine (Subutex)FDA LinkGeneric 10/2011
1	Pregabalin (Lyrica)FDA Link 10/2011
1	Nerve Growth Factor (NGF)IBA 10/2011
1	AZD1386IBA 05/2011
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2009
1	incobotulinumtoxinA FDA Link 10/2009
1	CollagenIBA 09/2009
1	ElastinIBA 09/2009
1	N 30IBA 10/2004
1	Melitten (Melittin)IBA 02/2003
1	Bee Venoms (Bee Venom)IBA 02/2003
1	BradykininIBA 01/2000

Therapy/Procedure

4	Therapeutics 01/2020 - 10/2005
3	Vagus Nerve Stimulation 01/2021 - 04/2016
3	Analgesia 05/2015 - 07/2014
3	Lasers (Laser) 10/2009 - 02/2003
2	Intradermal Injections 09/2003 - 02/2003
1	Neoadjuvant Therapy 01/2020
1	Pain Management 01/2017
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2017
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 01/2017
1	Electrodes (Electrode) 03/2013
1	Aftercare (After-Treatment) 10/2004
1	Cholecystectomy 10/2004
1	Bite Force (Occlusal Forces) 02/2001